J. Sokol

Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells.

W. Schiemann, Jonathan P Sokol, J. Sokol, 2004, Molecular cancer research : MCR.

The use of cystatin C to inhibit epithelial–mesenchymal transition and morphological transformation stimulated by transforming growth factor-β

W. Schiemann, B. Schiemann, J. Neil, 2005, Breast Cancer Research.

Integrative genomic profiling of hepatocellular adeno- mas identify mutational processes involved in malignant transformation

F. Suchy, C. Spino, F. Bendtsen, 2013 .